Product Images Clopidogrel
View Photos of Packaging, Labels & Appearance
- 64a55883 ada5 4769 e053 2a91aa0ae5f6
- image description - clopidogrel 01
- image description - clopidogrel 02
- image description - clopidogrel 03
- image description - clopidogrel 04
- image description - clopidogrel 05
- image description - clopidogrel 06
- image description - clopidogrel 07
- image description - clopidogrel 08
- image description - clopidogrel 09
- image description - clopidogrel bottle label 03
- image description - clopidogrel bottle label 09
- image description - clopidogrel bottle label 50
Product Label Images
The following 13 images provide visual information about the product associated with Clopidogrel NDC 71717-101 by Megalith Pharmaceuticals Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
64a55883 ada5 4769 e053 2a91aa0ae5f6
image description - clopidogrel 01
image description - clopidogrel 02
image description - clopidogrel 03
This appears to be a medical study or report comparing the incidence of cardiovascular death, myocardial infarction, and stroke in patients receiving either placebo or clopidogrel (in combination with aspirin) over a period of 12 months. The chart shows a significant reduction in the cumulative event rate for patients receiving clopidogrel compared to placebo, with a p-value of 0.00009.*
image description - clopidogrel 04
This is a statistical table showing various patient baseline characteristics and on-study concomitant medications/interventions for the CURE study. The characteristics include age, gender, race, cardiovascular health status, diabetes status, and medication usage such as Heparin/L MWH, Aspirin, GPIbIIIa Antag, Beta-Blocker, Ace Inhibitor, etc. The hazard ratio (95% CI) is also reported. More details on the specific results of the study are not available from this text.*
image description - clopidogrel 05
The text shows a comparison of the death rate between Placebo and Clopidogrel, which are two different treatments. The data mentions the number of deaths and the percentage of deaths for each treatment. The graph indicates the proportion of deaths before and after the treatment, as well as the days since randomization.*
image description - clopidogrel 06
image description - clopidogrel 07
This text provides a data table showing information about a medical study. The table includes data such as gender, age, hours since onset, SBP, heart rate and fibrinolytic agent given. The table also shows the numbers and percentages of patients who received Plavix or placebo along with, a statistical analysis of the data.*
image description - clopidogrel 08
image description - clopidogrel 09
image description - clopidogrel bottle label 03
This appears to be a prescription label for the medication Clopidogrel. The label includes information such as the medication strength (75 mg), dosage instructions, and the pharmacy's location.*
image description - clopidogrel bottle label 09
This is a package of 90 tablets of Clopidogrel, with NDC code 71717-101-03. The recommended adult dosage is 75mg per day. There is also a reference to "Darbussby" and "ROy eg".*
image description - clopidogrel bottle label 50
Clopidogrel is a medication available in tablet form with a strength of 75mg. The therapy is known for its properties in preventing blood clots and is primarily used for patients who have a higher risk of developing complications from cardiovascular disease. The medication is produced by Wngalin Pharmaceuticals, and it comes in a sex pack. The text also mentions the NDC code and the date of production.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
